Beta bionics announces participation at upcoming investor conferences

Irvine, calif., aug. 21, 2025 (globe newswire) -- beta bionics, inc. (nasdaq: bbnx), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at three upcoming investor conferences (all eastern time): wells fargo 20th annual healthcare conference on thursday, september 4, 2025 at 3:45pm morgan stanley 23rd annual global healthcare conference on monday, september 8, 2025 at 1:50pm baird 2025 global healthcare conference on wednesday, september 10, 2025 at 9:40am the presentations at the wells fargo and morgan stanley conferences will be webcast live.
BBNX Ratings Summary
BBNX Quant Ranking